Buy & Sell ACADIA Pharmaceuticals Inc. (ACAD) – ACADIA Pharmaceuticals Inc. Price Today
Aura AI Summary
Key Stats
- $3.80BMarket Cap
- HealthSector
- -18.78%3M Drawdown
- $3.00BEnterprise Value
- -Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 73 daysTypical Hold Time
ACADIA Pharmaceuticals Inc. (ACAD) is currently valued at a market capitalization of $3.80B, with an enterprise value of $3.00B. Over the past 52 weeks, ACADIA Pharmaceuticals Inc. has traded between a low of $17.16 and a high of $28.06, highlighting its annual price range. Over the past three months, ACADIA Pharmaceuticals Inc. has recorded a drawdown of -18.78%, reflecting recent price volatility. On average, investors hold ACADIA Pharmaceuticals Inc. for approximately 73 days, indicating typical investor behavior on the platform.
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Most Recent News
Exclaimer adds UKG Ready integration to automate HR-managed employee data in email signatures.
Exclaimer has launched a new integration with UKG Ready, expanding its HRIS integration capabilities to automate the synchronization of employee data from HR systems into email signatures and meeting themes. This move addresses the growing trend of o...
Rogers invests $22M to upgrade 5G+ network in Toronto for FIFA World Cup fans
Rogers Communications is investing $22 million to enhance its 5G+ network around BMO Field and nearby areas in Toronto ahead of the 2026 FIFA World Cup. The upgrade includes adding wireless infrastructure equivalent to 16 cell towers, deploying addit...
Thailand's elevator and escalator market to grow 3.2% CAGR through 2031 amid urbanization and construction boom
The Thailand elevator and escalator market is projected to grow at a compound annual growth rate (CAGR) of 3.2% from 2025 to 2031, driven by rapid urbanization and expanding commercial infrastructure. Key players like Otis, KONE, and Mitsubishi domin...